Natasha Barrow

1 day ago | insights.citeline.com | Natasha Barrow

Dxcover Launches US Operations With New Headquarters In Tennessee Infrared Spectroscopy Liquid Biopsy Startup Seeks New US Partnerships Dxcover sets up new Clinical Laboratory Improvement Amendments (CLIA) lab in Franklin, Tennessee. Dxcover sets up new facilities in Nashvillle, Tennessee.

2 days ago | insights.citeline.com | Natasha Barrow

Fallouh Healthcare Receives Grant Funding From Innovate UK UK Birmingham-Based Startup Develops Cardiac Tamponade Device Fallouh Healthcare has received £305,050 in grant funding from Innovate UK as part of the European Union’s Eureka Eurostars program. The company aims to detect cardiac tamponade, a condition that affects patients after heart surgery. Currently, there is no way to accurately diagnose the condition.

3 days ago | insights.citeline.com | Natasha Barrow

FDA Regulations ‘Lock Out’ Clinically Proven Neuromodulation Devices Flow Neuroscience CEO Says US Population Left With Untested Wellness Products Flow Neuroscience's neuromodulation headset for the treatment of depression is approved and marketed in the EU. However, two years on, the company is still waiting for US FDA approval despite being assigned breakthrough device designation.

3 days ago | insights.citeline.com | Natasha Barrow

UK MHRA Joins New Global Network For Safe Use Of AI In Healthcare HealthAI Global Regulatory Network Invites 10 Pioneering Countries To Join The UK's regulatory agency is the first to join a new international network for oversight of AI in healthcare run by a non-profit organization, HealthAI, the global agency for responsible AI in health. Patients should be at the center of AI tool development for clinical research. (Shutterstock)

4 days ago | insights.citeline.com | Natasha Barrow

Home-Testing Added To UK National Cervical Cancer Screening Program Potential Test Providers Include Hologic, Rovers Medical Devices And Copan Diagnostics NHS England will offer at-home cervical cancer self-testing kits to people who are overdue for routine screening by six months. The Department of Health and Social Care identified four HPV collection and testing combinations with highest accuracy.